Zen Technologies reports loss of Rs 1.8cr for Q3 FY22

Zen Technologies Limited has reported a loss after tax for the third quarter of the fiscal year 2022 (Q3 FY22) at INR 1.8 crores, compared to profit after tax (PAT) of INR 1.75 crores in the same period of the previous fiscal year.

The loss per share (EPS) of the Indian anti-drone technology and defense training solutions provider for the reported quarter was INR 0.16, compared to an EPS of INR 0.29 for Q3 FY21.

Zen Technologies earned a total income of INR 27.99 crores in Q3 FY22, compared to INR 17.3 crores in the corresponding quarter of the previous fiscal year.

See also  Trigyn Technologies wins Rs 35cr LokOS project from Digital India Corp

The company said that its total order book stood at INR 122.62 crores as of 31 December 2021, while the sale of equipment fetched it INR 298.37 crores.

Zen Technologies is engaged in manufacturing land-based military training simulators, live range equipment, driving simulators, and anti drone systems.

Zen Technologies, an Indian anti-drone technology and defense training solutions provider, reports loss of Rs 1.8cr for Q3 FY22
Zen Technologies, an Indian anti-drone technology and defense training solutions provider, reports loss of Rs 1.8cr for Q3 FY22. Photo courtesy of S. Hermann & F. Richter from Pixabay.

Ashok Atluri — Chairman and Managing Director of Zen Technologies said: “I am pleased to provide you with an update on our performance in Q3FY22. Our revenue streams were primarily driven by AMC’s during the third quarter. AMC’s contributed a total of INR 9.35 crores during the quarter, and in line with our strategic objectives, they have now started to cover the Company’s fixed operating costs.

See also  Torrent Power acquires 50MW solar power plant in Maharashtra

“While we suffered a minor setback as a result of the fire incident at our demonstration centre in Hyderabad, we are pleased to report that the previous quarter brought a fresh wave of growth opportunities. Not only did we receive our first export order for ‘Live Simulators’, but our subsidiary Unistring Tech Solutions Private Limited also secured its largest order to date, worth ~ INR 61 crores, from an Indian defence PSU.”

See also  Zydus Lifesciences gets FDA final approval for Acyclovir Cream

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.